* Artivion Inc AORT.N reported a quarterly adjusted loss
of 5
cents per share for the quarter , higher than the same quarter
last year, when the company reported EPS of -24 cents. The mean
expectation of six analysts for the quarter was for a loss of 6
cents per share. Wall Street expected results to range from -14
cents to -1 cents per share.
* Revenue rose 9% to $95.78 million from a year ago;
analysts
expected $94.76 million.
* Artivion Inc's reported EPS for the quarter was a loss
of 5
cents.
* The company reported a quarterly loss of $2.29 million.
* Artivion Inc shares had risen by 8.9% this quarter and
gained 62.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 9.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Artivion Inc is
$33.00
This summary was machine generated from LSEG data November 8 at
09:02 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.06 -0.05 Beat
Jun. 30 2024 -0.02 -0.05 Missed
Mar. 31 2024 -0.09 0.06 Beat
Dec. 31 2023 -0.10 -0.10 Met